Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zoetis
(NY:
ZTS
)
158.50
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Zoetis
< Previous
1
2
3
4
5
6
7
8
9
Next >
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
May 01, 2024
Despite the post-pandemic slowdown, the pet care industry remains healthy, as these three AI pet stocks to buy now demonstrate.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
Via
Benzinga
1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation
April 30, 2024
The temporary problems facing Zoetis could create an incredible opportunity for investors thinking decades ahead.
Via
The Motley Fool
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Zoetis Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
April 23, 2024
Via
Benzinga
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
April 19, 2024
The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvidia's stock falling into correction territory for the second time this month.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
April 16, 2024
Via
Benzinga
A Closer Look at Zoetis's Options Market Dynamics
April 12, 2024
Via
Benzinga
Masters In Trading - Saturday, April 13
April 13, 2024
In this recap of the most recent trading session, I review the trades I took throughout the week. I also discuss how to manage one's trades.
Via
Talk Markets
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 12, 2024
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
Via
Benzinga
Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats
April 12, 2024
Zoetis' Solensia and Librela, pioneering arthritis treatments for pets. Despite recent concerns, Zoetis defends their safety record, emphasizing positive outcomes for millions of treated animals.
Via
Benzinga
(ZTS) - Analyzing Zoetis's Short Interest
April 10, 2024
Via
Benzinga
Expert Outlook: Zoetis Through The Eyes Of 4 Analysts
April 02, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
March 28, 2024
Via
Benzinga
Zoetis Stock Crumbles After Report Suggests Arthritis Shots Sickened Dogs, Cats
April 12, 2024
The company says the side effects represent a fraction of the 18 million injections given in the U.S. and abroad.
Via
Investor's Business Daily
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
Via
The Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?
April 01, 2024
The S&P 500 rose last month, but these stocks didn't.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine
March 27, 2024
The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoetis' Librela monoclonal antibody for osteoarthritis pain relief in dogs...
Via
Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
March 19, 2024
Via
Benzinga
Looking Into Zoetis's Recent Short Interest
March 08, 2024
Via
Benzinga
4 Analysts Have This To Say About Zoetis
February 20, 2024
Via
Benzinga
(ZTS) - Analyzing Zoetis's Short Interest
February 14, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
February 26, 2024
Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Zoetis (ZTS) Q4 2023 Earnings Call Transcript
February 13, 2024
ZTS earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday?
February 13, 2024
Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by the impact of a higher-than-expected inflation report.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Is ZOETIS INC (NYSE:ZTS) a Strong Candidate for Quality Investing?
February 12, 2024
Why Quality Investors Should Delve into ZOETIS INC (NYSE:ZTS) for Investment Opportunities.
Via
Chartmill
Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins
February 13, 2024
Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products.
Via
Benzinga
Drug Maker AbbVie Stock Sees RS Rating Jump To 81
February 05, 2024
AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81.
Via
Investor's Business Daily
Earnings Scheduled For February 13, 2024
February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.